WebSAN DIEGO, April 13, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on April 10, 2024 , the Compensation Committee of its Board of Directors granted inducement equity grants to five new employees, consisting of inducement restricted stock units, or RSUs, WebApr 11, 2024 · HC Wainwright increased their target price on shares of Travere Therapeutics from $36.00 to $40.00 and gave the company a buy rating in a research note on Tuesday, February 21st. Stifel Nicolaus ...
Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to …
WebApr 13, 2024 · SAN DIEGO, April 13, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on April 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to five new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 30,000 shares of its … WebTHIOLA® helps prevent cystine kidney stone formation in patients who are resistant to changes in diet and high fluid intake by keeping their cystine levels below the line of solubility. ... You may report negative side effects to Travere Therapeutics Medical Information at 1-877-659-5518, ... habitat for humanity las vegas tx
Help prevent the next cystine kidney stone THIOLA (tiopronin) …
WebTravere Therapeutics, Inc. 3611 Valley Centre Drive, Suite 300. San Diego, CA 92130 WebFeb 17, 2024 · Travere Therapeutics, Inc. is a biopharmaceutical company. It is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. ... Cholbam (cholic acid capsules), and Thiola and Thiola EC (tiopronin tablets). Chenodal, which is for the treatment of patients suffering ... WebTravere Therapeutics Inc (Travere Therapeutics), formerly Retrophin Inc, is a biopharmaceutical company that discovers, develops, acquires, and markets drugs for the treatment of rare diseases. The company’s products include thiola, chenodal and cholbam. It develops drugs for therapies to people living with rare kidney, liver, and metabolic ... habitat for humanity las vegas staff